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Liver transplantation is an established therapy for end-stage liver diseases. Graft rejection occurs unless the recipient receives 
immunosuppression after transplantation. This study aimed to explore the mechanism of acute rejection of liver allografts in 
rats pre-treated with total body irradiation to eliminate passenger lymphocytes and to define the role of CD4+CD25+ regulatory 
T cells in the induction of immunotolerance in the recipient. Male Lewis rats were used as donors and male DA rats were re-
cipients. Rats were randomly assigned to the following four groups: control group, homogeneity liver transplantation group, 
idio-immunotolerance group and acute rejection group. After transplantation, the survival time of each group, serum alanine 
aminotransferase, total bilirubin levels, number of Foxp3+CD4+CD25+ regulatory T cells, expression of glucocorticoid-induced 
tumor necrosis factor receptor on T cell subgroups, histopathology of the hepatic graft and spleen cytotoxic T lymphocyte lytic 
activity were measured. In the acute rejection group, where donors were preconditioned with total body irradiation before liver 
transplantation, all recipients died between day 17 and day 21. On day 14, serum alanine aminotransferase increased signifi-
cantly to (459.2±76.9) U L1, total bilirubin increased to (124.1±33.7) μmol L1 (P<0.05) and the ratio of Foxp3+CD4+CD25+ 
regulatory T cells decreased significantly to 1.50%±0.50% (P<0.05) compared with the other groups. Analysis of the T cell 
subpopulations in the acute rejection group varied from the other groups. Histological analysis showed typical changes of acute 
rejection in the acute rejection group only. Preconditioning of the donors with total body irradiation eliminated passenger 
lymphocytes of the liver graft, and thus affected the course of tolerance and induced acute rejection after liver transplantation. 
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In end-stage liver disease, liver transplantation is often per-
formed. One disadvantage of transplantation is that graft 
rejection occurs unless the recipient receives immunosup-
pression after transplantation. The liver is an immunologi-
cally privileged organ with a capability for immunotoler-
ance. Tolerance can be induced in some liver recipients af-
ter standard immunosuppression treatments. Previous stud-
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ies on combined liver and kidney, or combined liver and 
intestine transplantation have shown that liver grafts confer 
immunoprotection to the kidney or intestinal grafts. How-
ever, the mechanism of hepatic immunologic privilege is 
unknown [1]. Immunotolerance can be induced without 
immunosuppression in a mouse liver transplant model even 
when the transplant is fully major histocompatibility mis-
matched. Total body irradiation (TBI) is a form of radio-
therapy used primarily as part of the preparative regimen for 
haematopoietic stem cell (or bone marrow) transplantation. 
TBI in a bone marrow transplantation setting serves to de-
stroy or suppress the recipient’s immune system, thereby 
preventing immunologic rejection of transplanted donor 
bone marrow or blood stem cells. However, tolerance can 
be prevented by TBI of the donor before liver transplanta-
tion, although the mechanism for this process is unknown 
[2]. This study used Lewis rats as donors and DA rats as 
recipients to establish spontaneous immunotolerance and 
acute rejection in a rat orthotopic liver transplantation mod-
el. The aims of this study were to investigate the mechanism 
of acute rejection induced by elimination of passenger 
lymphocytes in the donor liver grafts by TBI, to define the 
role of CD4+CD25+ regulatory T cells (Tregs) in the induc-
tion of immunotolerance after liver transplantation, and to 
explore the mechanism of the immunologically privileged 
status of the liver. 
CD4+CD25+ Tregs have attracted considerable attention 
because of their suppressive effects on many kinds of im-
mune cells and their crucial roles in innate and adaptive 
immunity. The transcription factor forkhead box P3 (Foxp3) 
is an intracellular marker for Tregs, and expression of this 
protein is important for the proliferation of Tregs and for 
their suppressive effects. Tregs from Foxp3 knockout mice 
have a reduced proliferation capability and acquire auto-
immune diseases with multi-organ involvement [3]. Expres-
sion of glucocorticoid-induced tumor necrosis factor (TNF) 
receptor (GITR), a TNF receptor superfamily member, pro-
vides costimulatory signals that activate T cells and coun-
teracts the suppressive activity of CD4+CD25+ Tregs. This 
induces an up-regulation of the immune response, thus in-
tensifying the generation and development of autoimmune 
diseases [4,5]. The complicated interactions between GITR 
and Tregs are of interest and suggested the investigation of 
immunologic regulation in liver transplantation. Thus, we 
studied the mechanism of TBI-induced acute rejection of rat 
liver transplantation and the role of CD4+CD25+ Tregs in 
inducing immune tolerance. 
1  Materials and methods 
1.1  Experimental animals 
Male Lewis (RT-11) rats weighing 200250 g (Weitongli-
hua Biotechnology Company, Beijing, China) were used as 
donors and as recipients in some animal groups. Male DA 
(RT-1a) rats weighing 250–300 g (Haerbin Experimental 
Animal Center, Haerbin, China) were used as recipients. All 
rats were bred and maintained in the animal facilities at 
Nanjing Medical University under specific pathogen free 
conditions in accordance with the guidelines of Nanjing 
Medical University. No immunosuppression was given to 
the recipient rats. 
1.2  Allogeneic orthotopic liver transplantation in rats 
Orthotopic liver transplantation was performed following 
the improved Kamada method as previously described [6]. 
Rats that died within 5 d of transplantation were considered 
operative deaths and were not included in the study. 
1.3  Preconditioning with total body irradiation 
TBI was performed using a linear accelerator (MD2, Sie-
mens, Germany) under the following settings: 10 MVX ray, 
1000 rad dose, and 100 cm source-skin distance [7]. Donor 
rats were irradiated 24 h before liver transplantation in sep-
arate plexiglass boxes, each with a 2 cm thick surround and 
1.5 cm thick top and bottom walls. 
1.4  Experimental design 
Rats were randomly divided into 4 groups, with 12 donors 
and 12 recipients in each group as follows: (i) control group 
were Lewis rats in which no liver transplantation and TBI 
were performed; (ii) homogeneity liver transplantation 
group in which both donors and recipients were Lewis rats, 
and liver transplantations were performed with no special 
handling before operations; (iii) idio-immunotolerance 
group [8] in which the donors were Lewis rats and the re-
cipients were DA rats, and liver transplantations were per-
formed with no special handling before operations; (iv) 
acute rejection group [8] in which the donors were Lewis 
rats and the recipients were DA rats, and liver transplanta-
tions were performed after the donors were preconditioned 
with TBI 24 h before the surgical operation. The recipients 
were observed and evaluated for survival after surgery.  
Peripheral blood from 6 rats in each group was obtained 
on days 4 and 7 after surgery by tail cutting, and the rats 
were sacrificed to obtain peripheral blood, liver and spleen 
on day 14 after surgery. 
1.5  Assessment of liver function 
Blood samples were obtained from the tail vein. The serum 
concentrations of alanine transaminase (ALT) and total bil-
irubin (TB) were measured with an automatic biochemistry 
analyzer (UVIDEC-77, Japan). 
1.6  Analysis of T cell subpopulations 
To 50 μL of none-stimulated peripheral blood obtained 
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from each recipient or control rat, 9 μL of PerCp-conjugated 
anti-rat CD3 monoclonal antibody (mAb) (Beckman Coul-
ter Inc, Brea, CA, USA), 9 μL of FITC-conjugated anti-rat 
CD4 mAb (Beckman Coulter Inc.) and 9 μL of APC-Cy7- 
conjugated anti-rat CD8 mAb (Beckman Coulter Inc) were 
added. After haematolysis by lysis buffer and incubation in 
the dark at 4°C for 30 min, the blood was washed and re-
suspended in PBS. Then the blood cells were counted by 
FACSCanto (Becton Dickinson, Franklin Lakes, NJ, USA). 
The data were analyzed using a Beckman Coulter 
FACSDiva (Beckman Coulter Inc.). 
1.7  Analysis of Foxp3+CD4+CD25+ Treg 
To 50 μL of none-stimulated peripheral blood obtained 
from each recipient or control rats, 10 μL of anti-CD4-FITC 
(Beckman Coulter Inc) and 10 μL of anti-CD25-APC mAbs 
(Beckman Coulter Inc) were added and the blood was incu-
bated in the dark at 4°C for 30 min. After haematolysis and 
washing, intracellular staining was performed on 
CD4+CD25+ T cells using 1 mL Fixation/Perm buffer solu-
tion for 45 min. The cells were then washed and 1 μL of 
γ-Globulin was added to block the cells at 4°C for 15 min. 
The cells were then stained with 10 μL of PE-conjugated 
anti-rat Foxp3 mAb (Beckman Coulter Inc) or 10 μL of 
PE-IgG2b for isotype-control (provided by the human regu-
latory T cell kit, eBioscience company), in the dark at 4°C 
for 30 min. After washing twice, the cells were resuspended 
in 300 μL flow cytometry staining buffer, and were counted 
using FACSCanto. The data were subsequently analyzed 
using FACSDiva to calculate the percentage of 
Foxp3+CD4+CD25+ cells in the total lymphocyte population. 
1.8  Analysis of GITR 
Whole blood treated with heparin sodium was diluted with 
RPMIl640 culture media at a 1:1 volume ratio. Blood was 
stimulated using phorbol ester (167 μg L1) and ionomycin 
(l mg L1), and incubated in 50 mL L1 CO2 at 37°C for 6 h. 
After the above treatments, the whole blood obtained was 
used for measuring GITR. The Human regulatory T cell 
Staining kit used in our study was obtained from eBiosci-
ence, the RPMI1640 medium was from GIBCO, Phorbol 
ester and ionomycin were from Sigma, and calf serum was 
from Wuhan Sanli Biotechnology Company. A 50 μL sam-
ple of the whole blood obtained after stimulation was incu-
bated with 10 μL of anti-CD3-PerCp and 5 μL of an-
ti-CD8-APC-Cy7 mAbs in the dark at 4°C for 30 min. After 
haematolysis and washing with PBS, the resuspended cells  
were incubated in the dark at 4°C for 45 min with 10 μL 
anti-rat GITR-PE mAb (R&D Systems, Minneapolis, MN, 
USA) or 10 μL IgG1-PE (Beckman Coulter Inc) as an iso-
type-control. After washing, the cells were counted using 
FACSCanto and the data were analyzed using FACSDiva. 
1.9  Histological examination 
Livers were removed at the indicated time points and fixed 
in buffered 10% formalin. Four-micrometer paraffin-   
embedded sections were cut and stained with hematoxylin 
& eosin. 
1.10  TNF-α measurement by enzyme-linked immuno-
sorbent assay (ELISA) 
Fresh liver tissue was prepared 7 days after transplantation. 
Tissue was lysed in buffer (25 mmol L1 HEPES, pH 7.4, 
0.1% CHAPS, 5 mmol L1 MgCl2, 1.3 mmol L1 EDTA, 1.0 
mmol L1 EGTA) containing protease and phosphatase in-
hibitors. The presence of TNF-α in cleared lysates was 
measured by TNF-α ELISA (R&D Systems, Minneapolis, 
MN, USA) according to the manufacturer’s instructions, 
and adjusted to total protein concentration. 
1.11  Assessment of spleen cytotoxic T lymphocyte 
(CTL)-mediated lytic activity by lactate dehydrogenase 
(LDH) release assay  
A spleen leukomonocyte suspension was prepared for each 
group of rats. A tissue grinder was used to separate the cells 
in PBS. Then an LDH assay was used to analyze CTLs as 
previously described [9]. Briefly, splenic lymphocytes sus-
pended in 10% FCS RPMI1640 culture media were added 
to a 96-well plate as CTL effector cells. B16 cells were 
added to the effector cells as target cells. The cells were 
cultured in an atmosphere of 5% CO2 at 37°C for 24 h, then 
centrifuged at 1500 r min1 for 5 min, and the cell-free-  
supernatant was retrieved for analysis of LDH levels. After 
termination of the experiment, 50 μL of the supernatant was 
drawn from each well of the 96-well plates and 50 μL lith-
ium lactate (0.3 mol L1, pH 8.8) (Sigma-Aldrich Company, 
St. Louis, MO, USA) was added to each well and incubated 
in the dark at room temperature for 30 min. The absorbance 
of each well was determined to calculate the release of LDH. 
The lytic activity of CTLs was expressed in terms of the 
cytotoxicity of CTL to B16 and calculated using the fol-
lowing CTL formula [10,11]: 
LDH released by CTL the LDH idio-released by target cell
CTL Lytic Activity
maximum LDH released by target cell the LDH idio-released by target cell
 
1.12  Statistics 
Data are provided as mean±standard deviation. Kaplan- 
Meier survival graphs were constructed and Log rank test of 
the groups was used to calculate P-values. For comparison 
between groups, we used Chi-square test and Student- 
Newman-Keuls q test as appropriate and P<0.05 was con-
sidered statistically significant. 
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2  Results 
2.1  Survival in the acute rejection group was lower 
than in the other groups 
Survival of all rats in the control, homogeneity liver trans-
plantation and idio-immunotolerance groups exceeded 100 d, 
and there was no significant difference in survival between 
the three groups. Survival of rats in the acute rejection 
group was 17–21 d, which was significantly lower than for 
the control group, the homogeneity liver transplantation 
group and the idio-immunotolerance group (P<0.05) (Fig-
ure 1). 
2.2  Increased levels of ALT and TB were maintained 
in the acute rejection group 
The ALT and TB of rats in the homogeneity liver trans-
plantation group was increased on day 4, and recovered by 
day 14 after surgery. The ALT and TB of rats in the id-
io-immunotolerance group increased significantly (P<0.05) 
when compared with the control group and the homogeneity 
liver transplantation group on day 4 and day 7 after surgery. 
The ALT and TB of rats in the acute rejection group in-
creased significantly when compared with the control group 
and the homogeneity liver transplantation group and con-
tinued to increase until day 14 (P<0.05) (Figure 2). 
 
 
Figure 1  Kaplan-Meier survival curve. Survival rate of rats 16–26 days after operation. Survival of rats in the acute rejection group was significantly lower 
(*, P<0.05) than the other three groups. 
 
Figure 2  Analysis of alanine transaminase (ALT) and total bilirubin (TB). A, The ALT level of rats on days 4, 7 and 14 after operation. B, The TB level of 
rats on days 4, 7 and 14 after operation. 
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2.3  Changes in T cell subpopulations in the acute re-
jection group  
There was no difference in the percentage of CD3+ T cells 
between the transplant groups. Analysis of the T cell sub-
populations by flow cytometry showed no difference in the 
CD3+CD4+ T cell counts between the four groups. The 
number of CD3+CD8+ T cells in the acute rejection group 
increased significantly (P<0.05) compared to the homoge-
neity liver transplantation, idio-immunotolerance group and 
control groups while the CD4+/CD8+ cell ratio decreased 
significantly (P<0.05) (Figure 3A). 
The number of Foxp3+CD4+CD25+ Tregs or CD4+CD25+ 
T cells in the acute rejection group was lower than in the 
control, homogeneity liver transplantation and idio-immu- 
notolerance groups (P<0.05) (Figure 3B). 
In the peripheral blood of rats, most lymphocytes were in 
the quiescent stage and GITR expression was not detectable 
on T cells [4,5]. After culture with phorbol ester and iono-
mycin, GITR expression on T cells increased in all groups. 
The GITR expression level on T cells from the acute rejec-
tion group was significantly higher than that in the other 
groups (P<0.05) (Figure 3C).  
2.4  TNF-α levels in liver graft tissues were significantly 
higher in the acute rejection group 
Hepatic levels of TNF-α in the acute rejection group were 
significantly higher compared to those in the control, ho-
mogeneity liver transplantation and idio-immunotolerance 
groups (P<0.05) (Figure 4). 
2.5  CTL-mediated lytic activity in the acute rejection 
group increased continuously 
CTL-mediated lytic activity in the spleen of recipients in the 
acute rejection group increased continuously. The spleen 
CTL-mediated lytic activity of the recipients in the acute 
rejection group increased by 32.6%, and was higher than 
those in the control, homogeneity liver transplantation and 
idio-immunotolerance groups (P<0.05) (Figure 3D).  
2.6  Histological analysis showed typical changes of 
acute rejection only in the acute rejection group 
On day 14 after liver transplantation, no significant differ-
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(continued) 
 
Figure 3  Detection of T cell subpopulations in the peripheral blood and CTL-mediated lytic activity. A, There was no difference in the percentage of CD3+ 
T and CD3+CD4+ T cells between the transplant groups. The number of CD3+CD8+ T cells in the acute rejection group increased significantly (P<0.05), 
while the number of CD4+/CD8+ cells decreased significantly compared to the other groups (P<0.05). B, The ratio of Foxp3+CD4+CD25+ Tregs and the 
expression of CD4+CD25+ T cells in the acute rejection group was significantly lower than those in the other groups (P<0.05). C, In the control group, GITR 
expression was not detectable on T cells. GITR expression on increased T cells from all groups after culture with phorbol ester and ionomycin. The GITR 
expression level of T cells in the acute rejection group was significantly higher than that in the other groups (P<0.05). D, The spleen CTL-mediated lytic  
activity of the recipients in the acute rejection group increased by 32.6%, and was significantly higher than those in the other three groups (P<0.05). 
 
Figure 4  Hepatic levels of TNF-α in the acute rejection group were sig-
nificantly higher compared to those in the control, homogeneity liver 
transplantation and idio-immunotolerance groups (P<0.05). 
homogeneity liver transplantation, idio-immunotolerance 
and control groups (Figure 5A, B and D). However, in the 
acute rejection group, histological analysis showed changes 
typical of acute rejection including significant loss of 
hepatocytes, increased lymphocytic infiltration into the cen- 
tral-portal vein glisson, significant damage to the bile duct 
epithelium and coherence of inflammatory cells under the 
blood vessel endothelium (Figure 5C). 
3  Discussion 
Following allogeneic liver transplantation in animals such 
as rats and mice, idio-immunotolerance can be induced even 
when the transplant combination is fully major histocom-
patibility mismatched [12]. In our experiments, Lewis rats 
were used as donors and DA rats were used as recipients, 
and the latter survived for more than 100 d after surgery. 
However, serum ALT and TB levels significantly increased 
compared with the homogeneity liver transplantation group 
on days 4 and 7 after the transplant. There was no evidence 
of rejection as assessed by histological analysis of the he-
patic grafts on day 14. These findings suggest that when  
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Figure 5  Histological analysis of the liver on day 14 post-transplantation. 
In the acute rejection group, histological analysis showed changes typical 
of acute rejection with significant loss of hepatocytes, increased lympho-
cytic infiltration into the central-portal vein glisson, significant damage to 
the bile duct epithelium and coherence of inflammatory cells under the 
blood vessel endothelium (arrowheads). No significant difference was  
observed in the liver histology of the other three groups. 
Lewis rats were used as donors and DA rats as recipients, 
the hepatic graft suffered from rejection at an early stage after 
surgery but subsequently acquired idio-immunotolerance. 
TBI preconditioning of the rat donors 24 h before trans-
plantation eliminated lymphocytes in the liver and peripher-
al blood [7], thereby eliminating passenger lymphocytes in 
the graft. Our expression analysis showed an up-regulation 
of hepatic TNF-α mRNA after TBI preconditioning. Previ-
ous studies have reported that TNF-α levels increase in re-
cipients during acute rejection after homogeneity organ 
transplantation such as liver transplantation [13]. Our results 
showed that TBI preconditioning adversely affected immu-
notolerance and induced acute rejection, suggesting lym-
phocytes in the hepatic graft play an important role in the 
induction of immunotolerance after liver transplantation. 
Depletion of CD25+ T cells in mice induces the devel-
opment of autoimmune diseases [14], suggesting that a 
functional disturbance of CD4+CD25+ Treg also plays an 
important role in the pathogenesis of rejection following 
organ and/or cell transplantation [15,16]. Studies have also 
shown that CD4+CD25+ Tregs are associated with the in-
duction of immunotolerance after liver transplantation 
[17,18]. In our study, we found no difference in the per-
centage of peripheral blood CD3+CD8+ T cells between the 
Control and the Homogeneity Liver Transplantation groups. 
However, compared with these groups, the percentage of 
peripheral blood CD4+CD8+ T cells in the idio-immunotol- 
erance group, which were similar to the control group levels 
to begin with, increased on day 4 after surgery and contin-
ued to rise on day 7. In addition, CD3+CD8+ T cells down-
regulated HLA-DR, a marker of T cell activation. The cyto-
kine profile of CD3+CD8+ T cells tended toward Th2 polar-
ization [19]. These data suggested that proliferation and 
activation of CD3+CD8+ T cells occurred in the acute rejec-
tion group. Our results also suggested that overactivation of 
CD3+CD8+ T cells in the acute rejection group was the re-
sult of an immunosuppression disorder mediated by 
Foxp3+CD4+CD25+ Tregs and activation signals by GITR. 
Piccirillo et al. [20] reported that CD4+CD25+ Tregs 
suppress the proliferation and activation of CD3+CD8+ T 
cells by suppressing the secretion of IL-2 and upregulation 
of CD25. The numbers of Foxp3+CD4+CD25+ Tregs in the 
idio-immunotolerance group were significantly lower than 
those in the control and homogeneity liver transplantation 
groups from days 4 to 6, but returned to normal levels on 
day 14. This suggested that acute rejection after rat liver 
transplantation was a consequence of dyspoiesis of Tregs in 
vivo [21], which resulted in overactivation of CD3+CD8+ T 
cells. The number of CD3+CD8+ T cells in the idio-immu- 
notolerance group also increased during the early stages 
after surgery.  
Ronchetti et al. [22] reported that activation of GITR 
transforms CD4+CD25+ Tregs to responsive CD4+CD25+ T 
effector cells. Our study showed that the expression of 
GITR increased significantly in peripheral blood CD3+CD4+ 
T cells from the acute rejection group, and that the expres-
sion of GITR in peripheral blood CD3+CD4+ T cells and 
CD3+CD8+ T cells in the acute rejection group was signifi-
cantly higher than that in the control group. However, the 
number of the peripheral blood CD3+CD8+ T cells in the 
acute rejection group also increased. These observations 
suggested that although GITR signals provided costimula-
tory activation to T cells, CD3+CD8+ T cells might be more 
sensitive to costimulatory activation. Ronchetti et al. [22,23] 
reported that activated GITR T cells were more suscepti-
ble to CD3-induced apoptosis than GITR+/+ T cells, and that 
GITR signaling promoted the survival of T cells [24]. Thus, 
it is likely that the increase of GITR expressed by peripheral 
blood CD3+CD8+ T cells in the acute rejection group re-
sulted in the prolonged survival and increased percentage of 
peripheral blood CD3+CD8+ T cells in the acute rejection 
group. 
In summary, we found that GITR signaling induced pro-
liferation, activation, and survival in the acute rejection 
group through costimulatory activation of lymphocytes, and 
inhibited apoptosis, ultimately resulting in a disorder of the 





CD  cluster of differentiation 
Foxp3 forkhead box P3 
GITR glucocorticoid-induced tumor necrosis factor  
receptor 
ALT  alanine aminotransferase 
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TB  total bilirubin 
TBI  total body irradiation 
Tregs regulatory T cells 
TNF-α tumor necrosis factor-α 
FITC fluorescein isothiocyanate 
APC  allophycocyanin 
FACS fluorescence activated cell sorte 
PBS  phosphate buffered saline 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic  
acid 
CHAPS 3-[(3-cholamidopropyl)dimethylammonio]-1-  
propanesulfonate 
EDTA ethylene diamine tetra-acetic acid 
EGTA ethylene glycol tetra-acetic acid 
CTL  cytotoxic T lymphocyte 
LDH lactate dehydrogenase 
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